AstraZeneca is launching a review to consolidate its estimated $170 million media planning and buying account for direct-to-consumer pharmaceutical advertising. Incumbents Creative Media and Zenith Media
Services, both New York, are expected to be involved. An AstraZeneca spokeswoman could not be immediately reached for comment.
Copyright August 2000, Crain Communications Inc.